<PAGE>
===============================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT FILED PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT
(DATE OF EARLIEST EVENT REPORTED): JUNE 8, 2000
ENCHIRA BIOTECHNOLOGY CORPORATION
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
DELAWARE 0-21130 04-3078857
(STATE OR OTHER JURISDICTION OF (COMMISSION FILE NUMBER) (I.R.S. EMPLOYER
INCORPORATION OR ORGANIZATION) IDENTIFICATION NO.)
4200 RESEARCH FOREST DRIVE
THE WOODLANDS, TEXAS 77381
(ADDRESS OF PRINCIPAL
EXECUTIVE OFFICES
AND ZIP CODE)
(281) 364-6100
(REGISTRANT'S TELEPHONE NUMBER,
INCLUDING AREA CODE)
Energy BioSystems Corporation
(Former name)
================================================================================
<PAGE>
ITEM 5. OTHER EVENTS
On June 8, 2000, Enchira Biotechnology Corporation (the "Company")
issued a press release announcing that its stockholders had approved the
Company's name change from Energy BioSystems Corporation to Enchira
Biotechnology Corporation and filed a Certificate of Amendment (the "Amendment")
to the Company's Amended and Restated Certificate of Incorporation to effect
such name change on June 9, 2000.
The Amendment and the press release are filed as exhibits to this
Current Report on Form 8-K and are incorporated by reference herein.
ITEM 7. EXHIBITS
Exhibit 3.1 -- Certificate of Amendment to the
Amended and Restated Certificate of Incorporation
Exhibit 99.1 -- Press Release
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ENCHIRA BIOTECHNOLOGY CORPORATION
Date: June 22, 2000
By: /s/ Paul G. Brown, III
----------------------------------------
Paul G. Brown, III
Vice President, Finance and
Administration and Chief Financial
Officer
